Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc down on Monday (RX)

Automated Summaries - The Globe and Mail - Mon Apr 15, 4:01PM CDT

In trading today, Biosyent Inc shares closed at $8.64 after opening the day at $8.56. prices ranged from a low of $8.55 to a high of $8.64.

Shares dipped -0.12 percent from the previous day's close of $8.65.

Today across North America, the TSX Composite closed -0.95% at 21899.99, the S&P 500 closed -1.46% at 5123.41, the Dow Jones Industrial Average closed -1.24% at 37983.24 and the Nasdaq Composite closed -1.62% at 16175.09.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

Trading volume was 1,400 on 9 total trades, while having an average volume of 11,042 in the last five days.

Trading across the entire TSX-V saw 939 price advancers against 4,327 declines and 94 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, in the last 52 weeks, Biosyent Inc's shares have boosted 13.24%, while they have dipped -6.29% year-to-date.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $100.49 million on a float of 11,618 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc has an average recommendation of "Moderate Buy" based on 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe